Spinal Cord and Brain
Novel noninvasive neuromodulation
therapies for unmet clinical needs
SpineX Inc. is an early stage bioelectric medtech company developing Noninvasive Neuromodulation devices that leverages cutting-edge research from the lab of Dr. V Reggie Edgerton, PhD at UCLA. At SpineX we are committed to helping individuals with unmet clinical needs. Our goal is to use rigorously tested neuromodulation technologies to aid recovery and restoration of bladder, bowel, respiration, sexual and sensorimotor function.
Meet The Team
CLINICAL INDICATIONS IN DEVELOPMENT
SCONE™ Is a platform technology and is being developed for use in adults and pediatrics.
Our work builds on decades of basic science and preclinical and clinical research led by Dr. Reggie Edgerton, Dr. Parag Gad and colleagues at UCLA. The science behind SCONE™ Therapy is validated by multiple peer-reviewed publications over the last 10 years and demonstrate some novel scientific learnings that rejected age old dogma and highlight the potential clinical applications.
Fill in your information to reach out.